Something alarming is happening to older workers in the final decade of their careers… and almost nobody is talking about it.

Many Texas Republicans entered Tuesday’s election having known November as a formality. They ended the night in the political wilderness trying to make sense of what went so wrong.

I am an acupuncturist and nurse who loves cats🐱It has been 21 years since I developed a brain disease, and while I still ...

Danny Donnelly MLA said: “Every baby born in Northern Ireland should have the same opportunity for an early diagnosis of ...

Annexon (NASDAQ:ANNX) said it expects to report the month-15 primary-endpoint analysis from its Phase III ARCHER II trial of vonaprument in geographic atrophy, or GA, during the fourth quarter of 2026 ...

Duravyu missed wet AMD noninferiority twice, DAYBREAK met its end points, and optogenetics won the Nobel as son-vec posted ...

Ocugen Inc (OCGN) advances all three late-stage modifier gene therapy programs into Phase 3 with key data readouts expected in 2027, backed by $84.6 million in cash and new licensing deals.

The train journey, late last year, is still etched on my mind. My hip joints felt excruciatingly painful as I hobbled along ...

Pediatric dermatologists outline how to evaluate suspected topical steroid withdrawal, exclude mimics, and preserve family trust in eczema care.

Qure's AMT-130 data likely remains strong enough to support accelerated approval, which isn't priced into the stock at the ...

Direct exposure to semaglutide or GIP peptide did not cause atrophy, inflammation or mitochondrial impairment in primary ...

A late-breaking slot in Boston will bring fresh data on an experimental drug that aims to turn down tau production in the ...